Tredaptive

Nazione: Nuova Zelanda

Lingua: inglese

Fonte: Medsafe (Medicines Safety Authority)

Principio attivo:

Laropiprant 20mg;  ; Nicotinic acid 1000mg

Commercializzato da:

Merck Sharp & Dohme (New Zealand) Limited

INN (Nome Internazionale):

Laropiprant 20 mg

Forma farmaceutica:

Tablet

Composizione:

Active: Laropiprant 20mg   Nicotinic acid 1000mg Excipient: Colloidal silicon dioxide Croscarmellose sodium Hyprolose Hypromellose Lactose monohydrate Magnesium stearate Microcrystalline cellulose Sodium stearyl fumarate

Confezione:

Blister pack, Al/Al - 7 tablets, 7 tablets

Classe:

Prescription

Tipo di ricetta:

Prescription

Prodotto da:

F.I.S. Fabbrica Italiana Sintetici SpA

Dettagli prodotto:

Package - Contents - Shelf Life: Blister pack, Al/Al - 7 tablets - 7 tablets - 24 months from date of manufacture stored at or below 30°C - Blister pack, Al/Al - 14 tablets - 14 tablets - 24 months from date of manufacture stored at or below 30°C - Blister pack, Al/Al - 28 tablets - 28 tablets - 24 months from date of manufacture stored at or below 30°C - Blister pack, Al/Al - 56 tablets - 56 tablets - 24 months from date of manufacture stored at or below 30°C

Data dell'autorizzazione:

2007-08-29